What the Pharmaceutical Industry Requires from Lab Balances

[Article Title]

The requirements for laboratory balances in the pharmaceutical industry have undergone significant evolutions and changes in recent years. Driven by a general need for clarification and the goal of international harmonization, the major pharmacopeias — the United States Pharmacopeia (USP), European Pharmacopeia (Ph.Eur.), Japanese Pharmacopeia (JP), and Chinese Pharmacopeia (ChP) — have all fundamentally revised their chapters on balances and brought them into closer alignment.

Download this white paper from Sartorius to learn more about today’s regulations and how the quality of analytical results depends critically on balance reliability.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Yes, I consent to Sartorius AG keeping me informed. Learn more.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.